ScreenerHero

SANASana Biotechnology, Inc.

NAS · US · Healthcare · Biotechnology · sana.com
3.910USD-4.63%Mkt Cap: 1.17B $P/E: —

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with un…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap1.17B $
Enterprise Value1.04B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-244.17M $
Revenue/Share—
Last Price3.910 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.74
PEG—
EV/EBITDA-5.97
EV/Revenue—
P/S—
P/B8.46
EPS (TTM)-0.68
EPS (Forward)-0.56
52W Range
2.61033% of range6.550
52W High6.550 USD
52W Low2.610 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-151.77%
ROA-58.57%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-143.83M $
CapEx (TTM)938.00K $
FCF Margin—
FCF Yield0.35%
Net Debt-79.55M $
Net Debt/EBITDA0.46
Balance Sheet
Debt/Equity0.49
Current Ratio1.38
Quick Ratio1.30
Book Value/Sh0.4420 USD
Cash/Share0.5360 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.429 USD
Upside (mean)+115.6%
Target Range6.000 USD – 12.00 USD
$6.000+115.6% to mean$12.00
# Analysts7
Ownership
Shares Out.299.36M
Float190.98M
Insiders6.05%
Institutions77.58%
Short Interest
Short Ratio15.1d
Short % Float23.77%
Short % Out.14.08%
Shares Short42.15M
Short (prev mo.)38.70M
Technical
SMA 503.415 (+14.5%)
SMA 2003.707 (+5.5%)
Beta2.10
S&P 52W Chg18.16%
Avg Vol (30d)2.53M
Avg Vol (10d)2.73M
Technical Indicators
RSI (14)61.1
MACD0.1396
MACD Signal0.0839
MACD Hist.+0.0557
BB Upper4.035 USD
BB Middle3.481 USD
BB Lower2.926 USD
BB Width31.88%
ATR (14)0.2441 USD
Vol Ratio (20d)1.14x